Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/04/2006CN1277923C Conditional touchdown multiplex polymerase chain reaction
10/04/2006CN1277922C Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
10/04/2006CN1277921C Method for producing recombinant human lactoferrin in silkworm body by gene engineering technology
10/04/2006CN1277919C Synthetase gene for T.fusca mycose and method for preparing mycose
10/04/2006CN1277844C Novel human cyclin, its coding sequence and application
10/04/2006CN1277842C Tolerance gene of antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same and applications thereof
10/04/2006CN1277837C Method for separating residual DNA from soy sauce, soybean milk and tomato ketchup
10/04/2006CN1277581C Method for producing antithrombotic medicine by using silk-worm
10/03/2006US7115801 Soybean cultivar 0509243
10/03/2006US7115800 Seedless watermelon having small fruit
10/03/2006US7115798 Methods for regulated expression of triats in plants using multiple site-specific recombination systems
10/03/2006US7115797 Rodent model homozygous for membrane protein defect associated with angina and arrhythmias for identifying modulators of cardiovascular and cardiac disorders
10/03/2006US7115796 Used in the production of heat shock proteins (HSP) in large quantity and as a xenograft source for transplation ; has a better meat quality and exhibits an increased growth rate and a reduced backfat thickness
10/03/2006US7115795 Transgenic animals expressing salivary proteins
10/03/2006US7115794 Method for direct nucleic acid uptake
10/03/2006US7115793 Providing a living transgenic mouse whose genome comprises an expression cassette comprising a polynucleotide; administering to the living transgenic living mouse said analyte; andmonitoring expression of said light-generating protein
10/03/2006US7115753 Triaryl cation antibiotics from environmental DNA
10/03/2006US7115738 Hydroxyproline/phosphono oligonucleotide analogues, methods of synthesis and methods of use
10/03/2006US7115735 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis
10/03/2006US7115734 Nucleic acid, nucleic acid for detecting dechlorination bacteria, probe, method for detecting dechlorination bacteria and method for treating earth or underground water polluted by chlorinated ethylene or chlorinated ethane
10/03/2006US7115733 Rubisco promoters and uses thereof
10/03/2006US7115731 Vectors; cells; drug targets
10/03/2006US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53
10/03/2006US7115728 Adipocyte differentiation; obesity
10/03/2006US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin
10/03/2006US7115723 Humanized antibody specific for surface antigen pre-S1 of HBV and preparation method thereof
10/03/2006US7115719 Formulations and methods for denaturing proteins
10/03/2006US7115717 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy
10/03/2006US7115714 Binding to antibodies; wound healing agent; cell proliferation stimulant
10/03/2006US7115713 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
10/03/2006US7115712 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12
10/03/2006US7115711 Retinoid X receptor-interacting polypeptides and related molecules and methods
10/03/2006US7115708 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
10/03/2006US7115580 antisense compound targeted to human B7; use with antiinflammatory agents or immunosuppressants; modulation of T cell activation
10/03/2006US7115579 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
10/03/2006US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
10/03/2006US7115420 Transformed plant; Dna sequences
10/03/2006US7115418 Methods of proliferating undifferentiated neural cells
10/03/2006US7115415 Forstimulating or inhibiting angiogenesis and/or cardiovascularization in mammals
10/03/2006US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders
10/03/2006US7115413 Meiotic recombination in vivo of partially homologous DNA sequences
10/03/2006US7115410 Purified protein that exhibits beta -secretase activity, is expressed from a bacterial source; treating amyloidogenic diseases such as Alzheimer's disease.
10/03/2006US7115407 Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producing the same
10/03/2006US7115406 Recombinant method for making RSV reverse transcriptases and mutants thereof
10/03/2006US7115405 Recombinantly produced, enzymatically active, includes two amino acid motifs
10/03/2006US7115403 Expression of improved polynucleotide and polypeptide sequences encoding for eukaryotic enzymes, particularly oxidase enzymes; produced in conventional or facile expression systems.
10/03/2006US7115402 Isolated nucleic acid encoding polypeptide of given sequence; use in diagnosis, treatment, and/or prevention of various diseases
10/03/2006US7115400 Forming a template of the nucleic acid to be amplified, containing an oligonucleotide sequence Y at the 5' end and an oligonucleotide sequence Z at the 3' end, immobilizing the nucleic acid to a solid support at the 5' end; mixing with colony primers generating nucleic acid colonies
10/03/2006US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders
10/03/2006US7115396 Protein scaffolds for antibody mimics and other binding proteins
10/03/2006US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype
10/03/2006US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation
10/03/2006US7115393 Melanocortin-1 receptor and methods of use
10/03/2006US7115392 Polynucleotides encoding human vascular endothelial growth factor 2
10/03/2006US7115391 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
10/03/2006US7115390 Connective tissue growth factor fragments and methods and uses thereof
10/03/2006US7115389 Contacting L-alanine methyl ester as carboxy component and L-glutamine as amine component to an enzyme (E. coli JM 109) which catalyzes hydrolysis of amino acid ester to form a dipeptide; enzyme derived from a microorganism belonging to the genus Acetobacter
10/03/2006US7115381 Methods for treating cardiovascular disorders
10/03/2006US7115377 Cells for use as tools in the detection of modulators of cellular activity
10/03/2006US7115376 Fractionating polynucleotides by capillary electrophoresis in a sieving matrix
10/03/2006US7115373 Diagnosing allergies via measuring expression of nuclear orphan receptor (NOR-1 receptor) gene; identifying modulators for treating atopic dermatitis
10/03/2006US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition
10/03/2006US7115370 Facilitating the recovery of only one unique restriction fragment of each cDNA species in a collection of products; utilizing a labeled primer
10/03/2006US7115369 Functional nucleic acid probes and uses thereof
10/03/2006US7115360 Isolation and use of solid tumor stem cells
10/03/2006US7115271 Protein D—an IgD-binding protein of Haemophilus influenzae
10/03/2006US7115269 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries
10/03/2006US7115268 Peptides derived from homologous sequences of the family of staphylococcal and streptococcal toxins, which may be polymeric, that provide protection against, or reduce the severity of toxic shock and septic shock from bacterial infections
10/03/2006US7115260 Interleukin-1β converting enzyme like apoptotic protease-6
10/03/2006US7115258 Vesicular monoamine transporter gene therapy in parkinson's disease
10/03/2006US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation
10/03/2006CA2254889C A promoter gene for a porcine complement inhibitor
10/03/2006CA2103572C Stamen-specific promoters from corn
10/03/2006CA2063822C Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
09/2006
09/28/2006WO2006102684A2 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells
09/28/2006WO2006102652A2 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
09/28/2006WO2006102491A2 Alteration of plant embryo/endosperm size during seed development
09/28/2006WO2006102461A2 Influenza therapeutic
09/28/2006WO2006102395A2 Delivery systems and methods for diagnosing and treating cardiovascular diseases
09/28/2006WO2006102343A2 A root-preferred, nematode-inducible soybean promoter and its use
09/28/2006WO2006102255A1 Inhibition of biofilm formation
09/28/2006WO2006102188A2 Methods and compositions involving the s-ship promoter
09/28/2006WO2006101983A2 Chemically inducible expression of biosynthetic pathways
09/28/2006WO2006101938A1 Cis-acting regulatory elements from tripsacum dactyloides
09/28/2006WO2006101841A2 Seneca valley virus based compositions and methods for treating disease
09/28/2006WO2006101810A2 Theileria parva dna vaccines
09/28/2006WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins
09/28/2006WO2006101634A1 Müller cell specific gene therapy
09/28/2006WO2006101474A1 Methods and compositions for producing active vitamin k-dependent proteins
09/28/2006WO2006101457A1 Novel neural cell specific promoter and baculovirus and method for gene delivery
09/28/2006WO2006101441A2 Method for protein purification comprising heat incubation in acetic acidic solution
09/28/2006WO2006101283A1 Development of expression vector with penetratin as a method to enhance transdermal delivery of recombinant protiens
09/28/2006WO2006101272A1 Target protein and target gene for drug discovery and screening method
09/28/2006WO2006101266A1 Process for production of optically active hydroxymethyl -substituted phenylalanine
09/28/2006WO2006101239A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
09/28/2006WO2006101229A1 Probe array and process for producing the same
09/28/2006WO2006101201A1 Liposome capable of effective delivery of given substance into nucleus
09/28/2006WO2006101195A1 Novel microorganism and method of processing fresh coffee beans by using the same
09/28/2006WO2006101176A1 Microorganism capable of accumulating ultra high molecular weight polyester
09/28/2006WO2006101140A1 Novel protease, microorganism producing the same, and application thereof